Silk Road Medical is a medical device company focused on reducing the risk of stroke and its devastating impact. Co.'s product portfolio are: ENROUTE Transcarotid Neuroprotection System, which is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, which is a self-expanding, self-tapering stent that conforms to patient; ENHANCE Transcarotid Peripheral Access Kit, which is used in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire, which is used for navigating and crossing the target lesion for delivery of interventional devices. We show 20 historical shares outstanding datapoints in our SILK shares outstanding history coverage, used to compute SILK market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SILK market cap history over the course of time is important for investors
interested in comparing SILK's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SILK versus a peer is one thing; comparing
SILK market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SILK can fluctuate over the course of history.
With this page we aim to empower investors researching SILK by allowing them to research the SILK market cap history. |
Free SILK Email Alerts:
Video: The Importance of Market Cap
